ArticleVascular health and risk management2025

Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study.

Bin Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.